Respiratory Medicine Articles & Analysis: Older
31 news found
Marianna University School of Medicine, Department of Respiratory Medicine, Kawasaki, Japan. “Many patients with advanced disease continue to struggle to breathe, making even simple daily tasks difficult. ...
Krestin is presently the Scientific Director of EIBIR (the European Institute of Biomedical Imaging Research) and a member of the NAM (National Academy of Medicine) in the US. FRI SUPPORTS MOVE TO DATA-DRIVEN RESPIRATORY MEDICINE Radiologists’ interpretation of images has traditionally been something of an art. ...
ByFluidda
In the U.S., the Unyvero LRT and LRT BAL panels for rapid detection of lower respiratory tract infections such as pneumonia are FDA-cleared for tracheal aspirate samples and bronchoalveolar lavage fluids, respectively. Unyvero HPN and LRT BAL are the only syndromic multiplex PCR panels for lower respiratory tract infections that also include Pneumocystis ...
These analyses included patients ≥65 years old, those with co-morbidities associated with worse COVID-19 outcomes, and those who, at baseline, despite receiving low flow oxygen, had clinical signs of compromised respiratory function (defined as oxygen saturation of ≤ 92% or respiratory rate ≥ 21 breaths/min). ...
He thinks that combining advanced diagnostics with currently available therapeutics in a personalized medicine approach will greatly improve chronic respiratory care overall. ...
ByFluidda
Synairgen plc (LSE: SNG), the respiratory company developing SNG001, an investigational formulation for inhalation containing the broad-spectrum antiviral protein interferon beta, presented the sub-group analysis from its Phase 2, SG016 study on Saturday 23 April in an oral presentation at the 32nd European Congress of Clinical Microbiology & Infectious Diseases (ECCMID), ...
Lands, M.D., Ph.D., Director, Pediatric Respiratory Medicine, Pediatric Cystic Fibrosis Clinic, and Pediatric Pulmonary Function Laboratory, Montreal Children’s Hospital, McGill University Health Center, and Professor, Department of Pediatrics, Faculty of Medicine, McGill University. ...
(VIDA), the leader in lung and respiratory intelligence, has received market authorization in Japan for its VIDA Insights® software, paving the way for lung care teams to begin using the solution at the point of care. ...
Synairgen plc (LSE: SNG), the respiratory company developing SNG001, a formulation for inhalation containing the broad-spectrum antiviral protein interferon beta, today announces that the international Phase 3 SPRINTER trial of SNG001 in patients hospitalised with COVID-19 did not meet its primary or key secondary efficacy endpoints. SNG001 demonstrated a favourable safety profile and was well ...
Outcomes from a previous Lungpacer clinical study published in theFebruary 2022 edition of the American Journal of Respiratory Critical Care Medicine showed Lungpacer therapy strengthened the diaphragm 246% more, and improved lung function 128% more than patients who did not receive the therapy.[1] The growing body of research including more than 44 scientific ...
Jacksonville, FL– December 16, 2021 -- RCSM, a leader in respiratory and sleep medicine in Florida, and Spire Health, the leading digital healthcare company for respiratory remote patient monitoring (RPM), today announced a partnership to provide a remote monitoring service to respiratory patients in the Jacksonville area. ...
The idea: Use of the antimicrobial and tissueregenerating effect of cold plasma in medicine and care with a small, handy device for stationary and mobile use. ...
AcuPebble SA100, a small wearable device that enables automated, remote home testing to detect obstructive sleep apnoea (OSA) in adults, has obtained FDA 510(k) clearance as a Class II medical device in the USA. The device, which received a CE Mark as a Class IIa medical device in 2020, was developed and is commercialised by UK-based medical device company Acurable and builds on more than ten ...
Caroline Baxter, MD, is a Consultant Respiratory Physician at Manchester NHS Foundation Trust in the United Kingdom. ...
“While initially deployed to improve care of chronic respiratory disease patients, the system has shown promise in the detection of acute infection as well. ...
MediPines remains committed to working hand-in-hand with healthcare professionals and policy makers seeking to combat COVID-19 and other deadly respiratory diseases.” MediPines AGM100® MediPines AGM100 is the world’s first non-invasive gas exchange analyzer. It is a respiratory monitoring system used to rapidly assess a patient’s ...
“The ultimate goal in designing and engineering this respiratory solution was to improve clinical workflow efficiency and patient outcomes. ...
Hogaboam’s distinguished career encompasses more than 20 years of scientific experience. He is a Professor of Medicine and Research Scientist in the Women’s Guild Lung Institute at Cedars Sinai Medical Center, and an Adjunct Professor of Pathology at the University of Michigan Medical School. ...
This study is the latest in a line of research using the novel MediPines AGM100 to advance respiratory medicine in areas of extreme physiology. The AGM100 is fast becoming a standard tool of global researchers studying the respiratory system in extreme physiological environments due to its precision, comprehensiveness, and portability. ...
AcuPebble SA100, the first medical device to obtain the CE mark for the automated diagnosis of Obstructive Sleep Apnoea, has been announced as one of 12 exciting innovations to join the NHS Innovation Accelerator 2021. This award-winning programme identifies early-stage solutions which address the most pressing needs of the NHS, and supports them over three years as they scale across England for ...